Dan Maselli, M.D., is a board-certified internal medicine, gastroenterology, and obesity medicine physician and the associate director of research for True You Weight Loss, a weight loss center in Cary, North Carolina
The FDA has approved these medications for use in patients with type 2 diabetes and for weight loss in individuals meeting certain criteria, such as BMI and weight-related conditions
Track Progress Safely Your care continues with regular follow-up visits and objective monitoring
GLP-1 side effects (nausea, vomiting, constipation) are generally well-tolerated and diminish over time
Wait two full days after your next dose, then begin controlled UV sessions (1015 minutes of natural sunlight or UVA exposure)
Related Tirzepatide and Medical Weight-Loss Resources Learn more about online treatment in New York, self-pay pricing, tirzepatide dosing tools and current medication statistics